Please log in to determine if you are eligible to purchase PT Programs.
INFECTIOUS DISEASE, RESPIRATORY PANEL - IDR
IDR
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
Adenovirus 5 Three shipments per year
Bocavirus 5
Bordetella (pertussis, parapertussis, bronchiseptica, holmesii) 5
Chlamydia pneumoniae 5
Coronavirus 5
Human metapneumovirus 5
Influenza A 5
Influenza B 5
Legionella pneumophilia 5
Mycoplasma pneumoniae 5
Parainfluenza 5
Respiratory syncytial virus (RSV) 5
Rhinovirus/Enteroviru 5
SARS-CoV-2* 5

For programs that include more than one subspecialty of microbiology, per CLIA, your laboratory is required to test five specimens, three times a year, for each subspecialty your laboratory performs.

*SARS-CoV-2 specimens do not contain human genomic nucleic acid or human RNase P gene.

Program Information

  • Five 1.0-mL liquid specimens
  • Designed for molecular multiplex panel users

Shipping Schedule

  • Shipment A: February 26
  • Shipment B: July 1
  • Shipment C: November 18






Customers Who Bought This Item Also Bought
INFECTIOUS DISEASE, PNEUMONIA PANEL
VIEW DETAILS >